Cargando…
Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer Radiotherapy
BACKGROUND: A total of 10%–20% of patients develop long-term toxicity following radiotherapy for prostate cancer. Identification of common genetic variants associated with susceptibility to radiotoxicity might improve risk prediction and inform functional mechanistic studies. METHODS: We conducted a...
Ejemplares similares
-
STROGAR – STrengthening the Reporting Of Genetic Association studies in Radiogenomics
por: Kerns, Sarah L., et al.
Publicado: (2013) -
Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer
por: Kerns, Sarah L., et al.
Publicado: (2016) -
Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity
por: Ahmed, Mahbubl, et al.
Publicado: (2016) -
Machine Learning and Radiogenomics: Lessons Learned and Future Directions
por: Kang, John, et al.
Publicado: (2018) -
Radiogenomics and Radiomics in Liver Cancers
por: Saini, Aman, et al.
Publicado: (2018)